These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 8647752)
1. In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia. Edelstein PH; Edelstein MA; Lehr KH; Ren J J Antimicrob Chemother; 1996 Jan; 37(1):117-26. PubMed ID: 8647752 [TBL] [Abstract][Full Text] [Related]
2. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia. Edelstein PH; Edelstein MA Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571 [TBL] [Abstract][Full Text] [Related]
3. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia. Edelstein PH; Shinzato T; Doyle E; Edelstein MA Antimicrob Agents Chemother; 2001 Aug; 45(8):2204-9. PubMed ID: 11451675 [TBL] [Abstract][Full Text] [Related]
4. BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs. Edelstein PH; Shinzato T; Edelstein MA J Antimicrob Chemother; 2001 Nov; 48(5):667-75. PubMed ID: 11679556 [TBL] [Abstract][Full Text] [Related]
5. In vitro activities of fleroxacin against clinical isolates of Legionella spp., its pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia. Edelstein PH; Edelstein MA; Holzknecht B Antimicrob Agents Chemother; 1992 Nov; 36(11):2387-91. PubMed ID: 1489182 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia. Edelstein PH; Edelstein MA; Weidenfeld J; Dorr MB Antimicrob Agents Chemother; 1990 Nov; 34(11):2122-7. PubMed ID: 2073101 [TBL] [Abstract][Full Text] [Related]
7. Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia. Edelstein PH; Edelstein MA; Ren J; Polzer R; Gladue RP Antimicrob Agents Chemother; 1996 Feb; 40(2):314-19. PubMed ID: 8834872 [TBL] [Abstract][Full Text] [Related]
8. Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L. pneumophila pneumonia. Edelstein PH; Weiss WJ; Edelstein MA Antimicrob Agents Chemother; 2003 Feb; 47(2):533-40. PubMed ID: 12543655 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp. Higa F; Arakaki N; Tateyama M; Koide M; Shinzato T; Kawakami K; Saito A J Antimicrob Chemother; 2003 Dec; 52(6):920-4. PubMed ID: 14613952 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia. Edelstein PH; Higa F; Edelstein MA Antimicrob Agents Chemother; 2001 Oct; 45(10):2685-90. PubMed ID: 11557455 [TBL] [Abstract][Full Text] [Related]
11. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells. Stout JE; Arnold B; Yu VL Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila. Baltch AL; Smith RP; Ritz W Antimicrob Agents Chemother; 1995 Aug; 39(8):1661-6. PubMed ID: 7486896 [TBL] [Abstract][Full Text] [Related]
13. Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth of Legionella pneumophila in human monocytes. Smith RP; Baltch AL; Franke M; Hioe W; Ritz W; Michelsen P J Antimicrob Chemother; 1997 Nov; 40(5):673-8. PubMed ID: 9421315 [TBL] [Abstract][Full Text] [Related]
14. [Therapeutic efficacy of levofloxacin against a model of replicable Legionella pneumophila lung infection in DBA/2 mice]. Kashimoto Y; Kurosaka Y; Karibe Y; Uoyama S; Fujikawa K; Namba K; Otani T; Yamaguchi K Jpn J Antibiot; 2009 Oct; 62(5):452-9. PubMed ID: 20055122 [TBL] [Abstract][Full Text] [Related]
15. The antimicrobial activity of ciprofloxacin against Legionella species and the treatment of experimental Legionella pneumonia in guinea pigs. Saito A; Koga H; Shigeno H; Watanabe K; Mori K; Kohno S; Shigeno Y; Suzuyama Y; Yamaguchi K; Hirota M J Antimicrob Chemother; 1986 Aug; 18(2):251-60. PubMed ID: 3759736 [TBL] [Abstract][Full Text] [Related]
16. The effect of ofloxacin on the intracellular growth of Legionella pneumophila in guinea pig alveolar phagocytes. Fitzgeorge RB; Featherstone AS; Baskerville A J Antimicrob Chemother; 1988 Sep; 22 Suppl C():53-7. PubMed ID: 3182462 [TBL] [Abstract][Full Text] [Related]
17. Bactericidal effects of co-amoxiclav (amoxycillin clavulanic acid) against a Legionella pneumophila pneumonia in the immunocompromised weanling rat. Smith GM; Abbott KH; Sutherland R J Antimicrob Chemother; 1992 Oct; 30(4):525-34. PubMed ID: 1490922 [TBL] [Abstract][Full Text] [Related]
18. In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila. Sato T; Tateda K; Kimura S; Ishii Y; Yamaguchi K Antimicrob Agents Chemother; 2011 Apr; 55(4):1594-7. PubMed ID: 21220530 [TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp. Dubois J; St-Pierre C J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031 [TBL] [Abstract][Full Text] [Related]